FACT
NASDAQ · N/A
Fact Ii Acquisition Corp
$10.63
+0.00 (+0.00%)
FACT News19 articles
Jersey Mike’s Topples Chick-fil-A in Customer Satisfaction Rankings
Jersey Mike’s scored 84 in the 2026 American Customer Satisfaction Index, edging Chick-fil-A’s 83 to end its 11-year reign as top QSR, as value and digital pickup gain importance.
FDA Decisions Loom for ACHV and UNCY Amid Manufacturing Hurdles
ACHV dropped 9.5% as its FDA deadline passed with a manufacturing-related rejection expected; UNCY fell 2.8% ahead of a June 29 decision. Both stocks face third-party manufacturing issues.
Jersey Mike's Dethrones Chick-fil-A in Customer Satisfaction Rankings
Jersey Mike's Subs scored 84 in the 2026 ACSI restaurant study, edging out Chick-fil-A's 83 and ending its 11-year streak as the top-ranked U.S. quick-service chain.
T1 Energy Soars on Factory Grade Upgrade and Analyst Initiation
T1 Energy shares jumped 12% after its Texas solar module plant earned an 'A' grade in a key third-party review, drawing investor attention as Bernstein started coverage.
Eos Energy Surges on Second Battery Factory Launch
Eos Energy Enterprises (EOSE) shares surged 10.9% to $7.08 after starting commercial production at its second Pennsylvania battery plant, targeting 4 GWh annual capacity by end-2026. Investors weigh strong demand against dilution and cash burn risks.
Factorial Energy Debuts on Nasdaq, Shares Surge After SPAC Merger
Factorial Energy's stock jumped 16% to $13.80 in its first day of trading under the new ticker FAC following a SPAC merger that raised $100M for solid-state battery development.
SUNation Energy Skyrockets on Suniva Reverse Merger, Betting on U.S. Solar Manufacturing
SUNation Energy shares jumped 165% premarket on plans to merge with Suniva, shifting focus to domestic solar cell production. Pre-merger holders will own only 1.8% of the combined company.
Bluejay Diagnostics Stock Surges 171% on U.S. Manufacturing Deal, FDA Hurdle Remains
Bluejay Diagnostics shares surged 171% to $5.88 after announcing a U.S. manufacturing partnership for its Symphony sepsis-testing platform, but the stock faces risks from pending FDA clearance and ongoing capital needs.
Bluejay Diagnostics Surges on US Manufacturing Pact, but Funding Concerns Loom
Bluejay Diagnostics (BJDX) jumped up to 213% in premarket after a US manufacturing deal with Argonaut, but the stock is volatile as Symphony awaits FDA clearance and funding is needed.
Healthpeak Retreats After Hitting 52-Week High: Key Factors Ahead
Healthpeak dropped 1.85% Friday, ending a 2.9% weekly decline after a 52-week high. The REIT raised its 2026 FFO outlook; analysts are split. Jobs data and rates are key.
Quanta Services Stock Stalls After Weekly Loss; Key Factors to Watch
Quanta Services shares slipped 2.5% Friday, capping a 1.6% weekly decline. The stock remains near 10% below its May peak as investors weigh a buyback, analyst upgrade, and project risks.
Nebius Shares Rebound Pre-Market as AI Factory Plans Face Earnings Test
Nebius Group shares rose 3.53% to $185.42 in pre-market trading after Tuesday's drop, ahead of Q1 earnings. The company's AI factory plans and tech deal with Clarifai are in focus.
POET Technologies Stock Rises After Appointing New COO to Lead Manufacturing Scale-Up
POET Technologies shares jumped 2.95% to $14.31 after appointing Sandeep Kumar as COO to lead manufacturing scale-up in Malaysia. The stock outperformed a down market as investors focus on production execution.
Intel Shares Surge on Preliminary Apple Chip Manufacturing Deal
Intel shares surged 14% after a preliminary deal to manufacture chips for Apple was reported. The agreement could be a major win for Intel's foundry business.
Shenzhen Market Plunges as Growth Stocks Retreat Despite Positive Factory Data
Shenzhen stocks declined sharply on Tuesday, with the ChiNext board dropping 2.7%, as investor concerns over energy prices and supply chain risks overshadowed positive manufacturing data.
ImmunityBio Surges on NK-Cell Manufacturing Milestone, Anktiva Expansion Progress
ImmunityBio shares jumped 10.5% Friday following news of a completed scalable manufacturing process for its NK-cell therapy platform and regulatory progress for its drug Anktiva. The company also reported surging 2025 revenue.
NVIDIA, ABB Forge Factory AI Alliance to Bridge Simulation-Reality Gap
NVIDIA and ABB have announced a strategic partnership to embed NVIDIA's Omniverse platform into ABB's RobotStudio software, aiming to achieve near-perfect accuracy when transferring robot training from simulation to physical factories. The collaboration is a key move for NVIDIA to expand its industrial AI footprint beyond data centers.
Apple Shares Retreat on Manufacturing Shift and China Risk Vote
Apple shares declined approximately 1% to $271.41 in Thursday morning trading, ending a two-day advance. The move followed a shareholder vote rejecting a report on China supply-chain risks and news of expanded U.S. manufacturing.
Stellantis Plunges on €22.2B EV Charge, Gigafactory Halt
Stellantis shares dropped sharply after announcing a major strategic reset, including a €22.2 billion impairment and shelving European battery plant projects.